Endothelins in chronic diabetic complications
- 2 June 2003
- journal article
- review article
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 81 (6) , 622-634
- https://doi.org/10.1139/y03-053
Abstract
Endothelins are widely distributed in the body and perform several vascular and nonvascular functions. Experimental data indicate abnormalities of the endothelin system in several organs affected in chronic diabetic complications. In support of this notion, it has been shown that endothelin-receptor antagonists prevent structural and functional abnormalities in target organs of diabetic complications in animal models. Alterations of plasma endothelin levels have also been demonstrated in human diabetes. This review discusses the role of endothelins in the pathogenesis of chronic diabetic complications. The current experimental evidence suggests that endothelin-receptor antagonism may potentially be an adjuvant therapeutic tool in the treatment of chronic diabetic complications.Keywords
This publication has 124 references indexed in Scilit:
- Time‐dependent up‐regulation of endothelin‐A receptors and down‐regulation of endothelin‐B receptors and nitric oxide synthase binding sites in the renal medulla of a rabbit model of partial bladder outlet obstruction: potential clinical relevanceBJU International, 1999
- Characterization of the Advanced Glycation End-Product Receptor Complex in Human Vascular Endothelial CellsBiochemical and Biophysical Research Communications, 1999
- Diabetic cardiomyopathyCoronary Artery Disease, 1996
- Endothelin 1-21 Plasma Concentrations in Children and Adolescents with Insulin-Dependent Diabetes MellitusJournal of Pediatric Endocrinology and Metabolism, 1996
- Identification and characterization of two isoforms of an endothelin‐converting enzyme‐1FEBS Letters, 1995
- Regulation of Endothelin‐1 BiosynthesisaAnnals of the New York Academy of Sciences, 1994
- Diabetes mellitus and hypertension.Hypertension, 1992
- C-type natriuretic peptide inhibits thrombin- and angiotensin II-stimulated endothelin release via cyclic guanosine 3',5'-monophosphate.Hypertension, 1992
- Cloning and functional expression of human cDNA for the ETB endothelin receptorBiochemical and Biophysical Research Communications, 1991
- Presence of non‐selective type of endothelin receptor on vascular endothelium and its linkage to vasodilationFEBS Letters, 1991